Literature DB >> 23800643

Associations between structural and functional changes to the kidney in diabetic humans and mice.

David W Powell1, David N Kenagy, Shirong Zheng, Susan C Coventry, Jianxiang Xu, Lu Cai, Edward C Carlson, Paul N Epstein.   

Abstract

Type 1 and Type 2 diabetic patients are at high risk of developing diabetic nephropathy (DN). Renal functional decline is gradual and there is high variability between patients, though the reason for the variability is unknown. Enough diabetic patients progress to end stage renal disease to make diabetes the leading cause of renal failure. The first symptoms of DN do not appear for years or decades after the onset of diabetes. During and after the asymptomatic period structural changes develop in the diabetic kidney. Typically, but not always, the first symptom of DN is albuminuria. Loss of renal filtration rate develops later. This review examines the structural abnormalities of diabetic kidneys that are associated with and possibly the basis for advancing albuminuria and declining GFR. Mouse models of diabetes and genetic manipulations of these models have become central to research into mechanisms underlying DN. This article also looks at the value of these mouse models to understanding human DN as well as potential pitfalls in translating the mouse results to humans.
© 2013.

Entities:  

Keywords:  Diabetic nephropathy; Glomerulus; Mouse models; Renal morphology; Transgenic mice

Mesh:

Substances:

Year:  2013        PMID: 23800643      PMCID: PMC3770478          DOI: 10.1016/j.lfs.2013.06.016

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  87 in total

1.  Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.

Authors:  Hui John Zhao; Suwan Wang; Huifang Cheng; Ming-zhi Zhang; Takamune Takahashi; Agnes B Fogo; Matthew D Breyer; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2006-09-13       Impact factor: 10.121

2.  Parietal podocytes in normal human glomeruli.

Authors:  Jean Bariety; Chantal Mandet; Gary S Hill; Patrick Bruneval
Journal:  J Am Soc Nephrol       Date:  2006-08-30       Impact factor: 10.121

3.  Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome.

Authors:  Evangelia I Prodromidi; Richard Poulsom; Rosemary Jeffery; Candice A Roufosse; Patrick J Pollard; Charles D Pusey; H Terence Cook
Journal:  Stem Cells       Date:  2006-07-27       Impact factor: 6.277

4.  Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.

Authors:  Ravi Retnakaran; Carole A Cull; Kerensa I Thorne; Amanda I Adler; Rury R Holman
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

Review 5.  Advanced glycation end products: sparking the development of diabetic vascular injury.

Authors:  Alison Goldin; Joshua A Beckman; Ann Marie Schmidt; Mark A Creager
Journal:  Circulation       Date:  2006-08-08       Impact factor: 29.690

6.  Glomerulotubular junction abnormalities are associated with proteinuria in type 1 diabetes.

Authors:  Behzad Najafian; John T Crosson; Youngki Kim; Michael Mauer
Journal:  J Am Soc Nephrol       Date:  2006-04       Impact factor: 10.121

Review 7.  Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes.

Authors:  Giuseppe Remuzzi; Ariela Benigni; Andrea Remuzzi
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

8.  Characterization of susceptibility of inbred mouse strains to diabetic nephropathy.

Authors:  Zhonghua Qi; Hiroki Fujita; Jianping Jin; Linda S Davis; Yihan Wang; Agnes B Fogo; Matthew D Breyer
Journal:  Diabetes       Date:  2005-09       Impact factor: 9.461

Review 9.  Are glomerular volume differences between type 1 and type 2 diabetic patients pathologically significant?

Authors:  K E White; S M Marshall; R W Bilous
Journal:  Diabetologia       Date:  2007-02-27       Impact factor: 10.122

Review 10.  Renal albumin absorption in physiology and pathology.

Authors:  H Birn; E I Christensen
Journal:  Kidney Int       Date:  2006-02       Impact factor: 10.612

View more
  8 in total

1.  A novel mouse model of advanced diabetic kidney disease.

Authors:  Jean-Francois Thibodeau; Chet E Holterman; Dylan Burger; Naomi C Read; Timothy L Reudelhuber; Christopher R J Kennedy
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

2.  Psychosocial stress and changes in estimated glomerular filtration rate among adults with diabetes mellitus.

Authors:  Francis B Annor; Katherine E Masyn; Ike S Okosun; Douglas W Roblin; Michael Goodman
Journal:  Kidney Res Clin Pract       Date:  2015-08-19

3.  Lixisenatide as add-on treatment among patients with different β-cell function levels as assessed by HOMA-β index.

Authors:  Riccardo C Bonadonna; Lawrence Blonde; Mikhail Antsiferov; Rachele Berria; Pierre Gourdy; Mensud Hatunic; Viswanathan Mohan; Michael Horowitz
Journal:  Diabetes Metab Res Rev       Date:  2017-06-20       Impact factor: 4.876

4.  Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICAM-1 on endothelium.

Authors:  Fei Tong; Suhuan Liu; Bing Yan; Xuejun Li; Shiwei Ruan; Shuyu Yang
Journal:  Int J Nanomedicine       Date:  2017-10-24

Review 5.  Diabetes Mellitus Contributes to Idiopathic Pulmonary Fibrosis: A Review From Clinical Appearance to Possible Pathogenesis.

Authors:  Dongguang Wang; Yao Ma; Xiang Tong; Yonggang Zhang; Hong Fan
Journal:  Front Public Health       Date:  2020-06-03

6.  Renoprotective, anti-oxidative and anti-apoptotic effects of oral low-dose quercetin in the C57BL/6J model of diabetic nephropathy.

Authors:  Isabele B S Gomes; Marcella L Porto; Maria Carmen L F S Santos; Bianca P Campagnaro; Thiago M C Pereira; Silvana S Meyrelles; Elisardo C Vasquez
Journal:  Lipids Health Dis       Date:  2014-12-06       Impact factor: 3.876

7.  Impaired Albumin Uptake and Processing Promote Albuminuria in OVE26 Diabetic Mice.

Authors:  Y S Long; S Zheng; P M Kralik; F W Benz; P N Epstein
Journal:  J Diabetes Res       Date:  2016-10-16       Impact factor: 4.011

8.  Ameliorative Effects of Bredemolic Acid on Markers Associated with Renal Dysfunction in a Diet-Induced Prediabetic Rat Model.

Authors:  Akinjide Moses Akinnuga; Angezwa Siboto; Bongiwe Khumalo; Ntethelelo Hopewell Sibiya; Phikelelani Ngubane; Andile Khathi
Journal:  Oxid Med Cell Longev       Date:  2020-06-22       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.